Navigation Links
Medivation Announces Third Quarter 2010 Financial Results Teleconference and Webcast on November 5, 2010
Date:10/29/2010

SAN FRANCISCO, Oct. 29 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) today announced that it will host a teleconference and webcast with management to discuss third quarter 2010 financial results and provide a general business update on November 5, 2010, at 4:30 p.m. Eastern Time. A press release for the third quarter ended September 30, 2010 will be released after markets close on November 5, 2010.

Interested parties may call 877-303-2523 from the U.S. or +1-253-237-1755 internationally. Individuals interested in listening to the live call via webcast may do so by visiting http://www.medivation.com. A replay of the webcast will be available on the Company's website for 30 days.

About Medivation

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. Together with its corporate partners Pfizer and Astellas, Medivation currently has investigational drugs in Phase 3 development to treat advanced prostate cancer, mild-to-moderate Alzheimer's disease and Huntington disease. For more information, please visit us at www.medivation.com.


'/>"/>
SOURCE Medivation, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Medivation Announces Second Quarter 2010 Financial Results Teleconference and Webcast on August 9, 2010
2. Medivation Announces Organizational Changes to Support Anticipated Growth and Future Commercialization
3. Medivation Reports Third Quarter 2009 Financial Results and Provides Corporate Update
4. Astellas and Medivation Enter Into Worldwide Agreement to Co-Develop and Co-Commercialize MDV3100 for the Treatment of Prostate Cancer
5. Medivation Announces Initiation of Phase 3 Clinical Trial of MDV3100 in Advanced Prostate Cancer
6. Medivation Announces Positive New Efficacy Data From Phase 1-2 Trial of MDV3100 in Advanced Prostate Cancer Patients
7. Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimers Disease
8. Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients
9. Medivation Presents Positive New Data on Dimebons Long-Term Efficacy and Novel Mechanism of Action at the International Conference on Alzheimers Disease
10. Medivation Announces Publication in The Lancet of Dimebon Pivotal Trial Results in Alzheimers Disease
11. Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntingtons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... , February 26, 2015 ... Outlook 2015: First -In- Class Innovations and Cost ... for Large Cap Pharmaceutical Companies research report to ... According to this Global Pharma US & ... as productivity measurements, divestment of non-core assets result ...
(Date:2/26/2015)... , Feb. 26, 2015  Spring Bank ... therapeutics for the treatment of Hepatitis B virus ... closing of a $22 million financing. Funds from ... 9200, a novel, broad spectrum antiviral agent derived ... acid hybrid (SMNH) chemistry platform, into Phase II ...
(Date:2/26/2015)... 26, 2015 Integrity Applications, Inc. (OTCQB: IGAP) ... model DF-F, a noninvasive  device that tracks blood glucose ... Ph.D., will head its new scientific advisory board that ... field of Diabetes research, monitoring and treatment. ... Chief Executive Officer and Head, Business Development of Profil ...
Breaking Medicine Technology:Global Pharma U.S. and EU Outlook 2015 Market Research Report 2Global Pharma U.S. and EU Outlook 2015 Market Research Report 3Global Pharma U.S. and EU Outlook 2015 Market Research Report 4Spring Bank Pharmaceuticals Completes $22 Million Financing 2Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 2Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 3Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 4
... , , ... Remedies announced today that its NutraRx brand of natural ... country to receive the Emerson EQP Seal in recognition of the ... "After a rigorous evaluation by Emerson Ecologics of our NutraRx brand ...
... ALBUQUERQUE, N.M. , Feb. 16 ... develops and markets proprietary genomic tests, today announced an ... promote its diagnostic services to gastroenterologists throughout the ... gastroenterology-focused sales force will introduce Exagen,s proprietary gene expression ...
Cached Medicine Technology:Native Remedies' NutraRx Brand of Natural Products for Medical Practitioners Among First to Earn Prestigious 'Emerson EQP Seal' 2Native Remedies' NutraRx Brand of Natural Products for Medical Practitioners Among First to Earn Prestigious 'Emerson EQP Seal' 3Exagen Diagnostics Enters Into Exclusive Agreement With EndoChoice 2
(Date:2/27/2015)... NY (PRWEB) February 27, 2015 Ticket Down ... North America during the summer months of 2015. Tickets ... expected to sell out at a record pace. ... Tickets, Austin, TX Frank Erwin Center, Wednesday, May 6, 2015 ... at Grand Prairie, Thursday, May 7, 2015 , 5/9/15, Ed ...
(Date:2/27/2015)... February 27, 2015 Burien Nursing ... American Health Care, Inc. with the Facility of ... in four key areas: Outstanding quality of care / ... Administrator Lynda Baldwin was invited to attend the awards ... 2015. “I am delighted to receive this award on ...
(Date:2/27/2015)... 2015 RDI-Engineering will be hosting an ... event on March 14, at Moreno Valley College. The ... how to use engineering software and tools, and a ... by Moreno Valley College’s Upward Bound Math and Science ... in hopes to encourage students to seek educational and ...
(Date:2/27/2015)... February 27, 2015 Leading massage chair ... wellness to Americans nationwide. Each month they take a look ... and wellness, and healthy living. In the month of March ... Sleep Awareness Week starts by bringing awareness to the ... year Sleep Awareness Week will start on March 2nd, and ...
(Date:2/27/2015)... 27, 2015 ResearchMoz has announced ... the analysis of the cell culture protein surface ... discusses the current scenario and development prospects of ... for the period of 2015 to 2019. , ... , The research report, titled Global Cell ...
Breaking Medicine News(10 mins):Health News:Ed Sheeran Tickets at the Hollywood Bowl, Verizon Theatre, The Mann Center, Darlings Waterfront Pavilion, Moda Center, BOK Center, Consol Energy & Red Rocks Now On Sale 2Health News:Ed Sheeran Tickets at the Hollywood Bowl, Verizon Theatre, The Mann Center, Darlings Waterfront Pavilion, Moda Center, BOK Center, Consol Energy & Red Rocks Now On Sale 3Health News:Ed Sheeran Tickets at the Hollywood Bowl, Verizon Theatre, The Mann Center, Darlings Waterfront Pavilion, Moda Center, BOK Center, Consol Energy & Red Rocks Now On Sale 4Health News:Burien Nursing and Rehabilitation Center Receives Top Honors with Facility of the Year Award 2Health News:Burien Nursing and Rehabilitation Center Receives Top Honors with Facility of the Year Award 3Health News:RDI-Engineering Participates in STEM”U”LATE Your Mind Event to Host Educational Exhibition 2Health News:Emassagechair Wants Shoppers to Think About the Benefits of Massage During National Sleep Awareness Week 2Health News:Emassagechair Wants Shoppers to Think About the Benefits of Massage During National Sleep Awareness Week 3Health News:Global Cell Culture Protein Surface Coating Industry: Rising Focus towards Stem Cells Research to Trigger Market Growth 2Health News:Global Cell Culture Protein Surface Coating Industry: Rising Focus towards Stem Cells Research to Trigger Market Growth 3
... osteoporosis is useful, but changes in bone// mineral density ... anti-resorptive agents that prevent bone breakdown. ,For patients ... enhances bone formation is preferable, and this is now ... However, the use of PTH is limited by its ...
... University of Bath in England an interesting study has been ... men. This is despite the popular notion that the ... yet knows. ,“Until fairly recently it was controversial to suggest ... the perception and experience of pain, but that is no ...
... issue of the journal Thorax, researchers have emphasized// the ... into the data provided by 2401 subjects who had ... incidence of tuberculosis disease. Of the total subjects ... test. The research results have showed that the increase ...
... it will promote a culture of openness and enhanced// ... FDA will create a new independent Drug Safety Oversight ... and will provide emerging information to health providers and ... ,Specific proposals for immediate and fundamental steps to improve ...
... journal Thorax a study concludes that smoking may increase ... at 2,401 adults from two urban communities in Cape Town, ... and underwent a tuberculin skin test. Factors such as age, ... into account. ,Of 1,309 current smokers or ex-smokers, ...
... Drug Administration (FDA) today issued a public health advisory ... the suspended marketing of Tysabri (nataluzimab) while the agency ... with its use., ,Tysabri, which received accelerated approval ... that represents a new approach to treating patients with ...
Cached Medicine News:Health News:The Benefits of Strontium in the treatment for Osteoporosis Questioned 2Health News:Gender difference in Pain Experience - Women feel More Pain than men 2Health News:Monitoring Drug Safety 2Health News:FDA Issues Public Health Advisory on Tysabri, a New Drug for MS 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: